Literature DB >> 10791965

Selective stabilization of the high affinity binding conformation of glucagon receptor by the long splice variant of Galpha(s).

C G Unson1, C R Wu, T P Sakmar, R B Merrifield.   

Abstract

To analyze functional differences in the interactions of the glucagon receptor (GR) with the two predominant splice variants of Galpha(s), GR was covalently linked to the short and the long forms Galpha(s)-S and Galpha(s)-L to produce the fusion proteins GR-Galpha(s)-S and GR-Galpha(s)-L. GR-Galpha(s)-S bound glucagon with an affinity similar to that of GR, while GR-Galpha(s)-L showed a 10-fold higher affinity for glucagon. In the presence of GTPgammaS, GR-Galpha(s)-L reverted to the low affinity glucagon binding conformation. Both GR-Galpha(s)-L and GR-Galpha(s)-S were constitutively active, causing elevated basal levels of cAMP even in the absence of glucagon. A mutant GR that failed to activate G(s) (G23D1R) was fused to Galpha(s)-L. G23D1R-Galpha(s)-L bound glucagon with high affinity, but failed to elevate cAMP levels, suggesting that the mechanisms of GR-mediated Galpha(s)-L activation and Galpha(s)-L-induced high affinity glucagon binding are independent. Both GR-Galpha(s)-S and GR-Galpha(s)-L bound the antagonist desHis(1)[Nle(9),Ala(11),Ala(16)]glucagon amide with affinities similar to GR. The antagonist displayed partial agonist activity with GR-Galpha(s)-L, but not with GR-Galpha(s)-S. Therefore, the partial agonist activity of the antagonist observed in intact cells appears to be due to GRs coupled to Galpha(s)-L. We conclude that Galpha(s)-S and Galpha(s)-L interact differently with GR and that specific coupling of GR to Galpha(s)-L may account for GTP-sensitive high affinity glucagon binding.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10791965     DOI: 10.1074/jbc.M002093200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Conformational kinetics reveals affinities of protein conformational states.

Authors:  Kyle G Daniels; Yang Suo; Terrence G Oas
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-10       Impact factor: 11.205

2.  Mutational analysis of the glucagon receptor: similarities with the vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP)/secretin receptors for recognition of the ligand's third residue.

Authors:  Jason Perret; Mélanie Van Craenenbroeck; Ingrid Langer; Pascale Vertongen; Françoise Gregoire; Patrick Robberecht; Magali Waelbroeck
Journal:  Biochem J       Date:  2002-03-01       Impact factor: 3.857

3.  Quantification of G protein Gaalphas subunit splice variants in different human tissues and cells using pyrosequencing.

Authors:  Ulrich H Frey; Holger Nückel; Dobromir Dobrev; Iris Manthey; I E Sandalcioglu; Andreas Eisenhardt; Karl Worm; Hans Hauner; Winfried Siffert
Journal:  Gene Expr       Date:  2005

4.  Integrative RNA-omics Discovers GNAS Alternative Splicing as a Phenotypic Driver of Splicing Factor-Mutant Neoplasms.

Authors:  Emily C Wheeler; Shailee Vora; Daniel Mayer; Andriana G Kotini; Malgorzata Olszewska; Samuel S Park; Ernesto Guccione; Julie Teruya-Feldstein; Lewis Silverman; Roger K Sunahara; Gene W Yeo; Eirini P Papapetrou
Journal:  Cancer Discov       Date:  2022-03-01       Impact factor: 38.272

Review 5.  Skeletal progenitors and the GNAS gene: fibrous dysplasia of bone read through stem cells.

Authors:  Mara Riminucci; Pamela Gehron Robey; Isabella Saggio; Paolo Bianco
Journal:  J Mol Endocrinol       Date:  2010-09-14       Impact factor: 5.098

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.